BCAL

BDX.AX

Tags: AU Healthcare Medical - Diagnostics & Research

BCAL Diagnostics Limited Price (BDX.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

246,225,497

(16.7484)%

Market Cap of BCAL (BDX.AX)

Market cap:

As of , BDX.AX has a market cap of . This makes BDX.AX the 1875th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is h... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.086-0.185
Market Cap 35.13M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Diagnostics & Research

ceo: Mr. Shane Ryan M.B.A.
IPO Date: July, 21, 2021
Country: AU
Currency: AUD
Headquaters: Sydney, NSW
Employees: No Data

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: